Stock screenerAll disclosures →
EDGAR →
CYRX
Conviction 80HealthcareScan · Thu, Jun 25, 2026CYRX$15.86+2.19%
ResistanceSupportVol 14Insider sellVol MA14 765.45K
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price15.86
Change+2.19%
Gap+0.90%
Rel volume1.02×
Avg volume1.02M
Avg $ vol15.68M
SMA 2015.28
SMA 5013.27
SMA 20010.27
Price vs 50+19.53%
Price vs 200+54.41%
MA stackbullish
50/200 cross—
Supertrendup · 14.29
RSI (14)65
MACD hist-0.10
MACD cross—
Stoch %K / %D84 / 51
ADX (14)39
+DI / −DI29 / 13
RSI divergence—
MACD divergence—
ATR %+4.25%
ADR %4.47%
52w high16.50
52w low6.71
From 52w high-3.88%
Above 52w low+136.36%
New 52w highNo
SqueezeOff
Bollinger width15.39%
%B0.75
Donchian pos67.54%
Donchian high16.73
Donchian low14.05
AVWAP (52w high)15.20
vs AVWAP high+4.36%
AVWAP (52w low)10.48
vs AVWAP low+51.40%
OBV trendUp
Chaikin MF (20)0.14
Today vs 20d1.02×
Avg vol (14d)765.45K
Avg vol (20d)1.02M
Avg $ vol (20d)15.68M
Market cap799.38M
RS 3m (vs SPY)+78.17%
RS 6m (vs SPY)+57.02%
RS line new highNo
Trend template8/8
Technical rank92.9
1 week+8.85%
1 month+13.61%
3 months+88.59%
6 months+62.67%
1 year+117.26%
YTD+65.90%
P/E10.21
P/B1.61
P/S4.54
P/FCF-31.95
EPS1.40
Div yield—
ROE15.82%
ROA10.25%
Debt/Eq0.00
Current2.09
EV/EBITDA-58.03
Gross margin47.14%
Net margin44.44%
Rev growth12.38%
EPS growth168.23%
Price target14.83
Target upside-6.49%
Analyst ratingBuy
Institutional101.57%
Ent. value527.76M
Revenue47.8M
Net income-10.54M
Gross profit21.91M
Free cash flow-25.02M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out50.4M
Employees738
ListedFri, Jul 16, 1993
Free float48.24M
Float %96.1%
Short interest2.32M
Days to cover2.2d
Short volume30.0%
Squeeze score21 / 100
Next earningsTue, Aug 4, 2026 (40d)
EPS forecast−$0.20 · 1 est
Last EPS vs est−$0.23 vs −$0.20
Last surprise-15.0% miss
Setup gradeA
Conviction80 / 100
Pattern quality—
Tech rank92.9 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance15.55
Support13.31
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in CYRX
No recent disclosed trades by Congress in CYRX. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in CYRX · 8 buys · 2 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
BADDOUR LINDA Director · Common Stock · 2026-06-05 | Grant | 10.35K | $0 | 2026-06-05 | 2026-06-09 |
BADDOUR LINDA Director · Option (Right to Buy Common Stock) · 2026-06-05 | Grant | 16.08K | $0 | 2026-06-05 | 2026-06-09 |
Mandalam Ramkumar Director · Common Stock · 2026-06-08 | Sell | 23.21K | $358K | 2026-06-08 | 2026-06-08 |
Hariri Robert J Director · Common Stock · 2026-06-05 | Grant | 10.35K | $0 | 2026-06-05 | 2026-06-08 |
Mandalam Ramkumar Director · Option (Right to Buy Common Stock) · 2026-06-05 | Grant | 16.08K | $0 | 2026-06-05 | 2026-06-08 |
Hariri Robert J Director · Option (Right to Buy Common Stock) · 2026-06-05 | Grant | 16.08K | $0 | 2026-06-05 | 2026-06-08 |
HANCOCK DANIEL M Director · Option (Right to Buy Common Stock) · 2026-06-05 | Grant | 16.08K | $0 | 2026-06-05 | 2026-06-08 |
HANCOCK DANIEL M Director · Common Stock · 2026-06-05 | Grant | 10.35K | $0 | 2026-06-05 | 2026-06-08 |
Mandalam Ramkumar Director · Common Stock · 2026-06-05 | Grant | 10.35K | $0 | 2026-06-05 | 2026-06-08 |
STEFANOVICH ROBERT Chief Financial Officer · Common Stock · 2026-06-04 | Sell | 169.43K | $2.8M | 2026-06-04 | 2026-06-08 |
SEC filings
EDGAR filings in CYRX · 5 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.